Mitchell & Pahl Private Wealth, LLC Charles River Laboratories International, Inc. Transaction History
Mitchell & Pahl Private Wealth, LLC
- $228 Million
- Q4 2025
A detailed history of Mitchell & Pahl Private Wealth, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Mitchell & Pahl Private Wealth, LLC holds 5,102 shares of CRL stock, worth $856,166. This represents 0.37% of its overall portfolio holdings.
Number of Shares
5,102
Previous 5,128
0.51%
Holding current value
$856,166
Previous $802,000
6.73%
% of portfolio
0.37%
Previous 0.35%
Shares
19 transactions
Others Institutions Holding CRL
# of Institutions
656Shares Held
51.7MCall Options Held
194KPut Options Held
174K-
Vanguard Group Inc Valley Forge, PA5.89MShares$988 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$854 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.19MShares$535 Million0.09% of portfolio
-
Allspring Global Investments Holdings, LLC2MShares$335 Million0.62% of portfolio
-
State Street Corp Boston, MA1.83MShares$307 Million0.01% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.54B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...